BIOA Latest Headlines

Analysts’ Opinions Are Mixed on These NA Stocks: BioAge Labs, Inc. (BIOA) and Fiserv (FISV)

at www.tipranks.com (Thu, 6-Aug 7:40 PM)

Oppenheimer Sticks to Its Buy Rating for BioAge Labs, Inc. (BIOA)

at www.tipranks.com (Thu, 6-Aug 9:07 AM)

BioAge Labs: Upstream NLRP3 Strategy and Strong Cash Runway Underpin Unchanged $35 Price Target and Buy Rating

at www.tipranks.com (Thu, 6-Aug 8:25 AM)

Analysts Are Bullish on These NA Stocks: BillionToOne, Inc. Class A (BLLN), Carlsmed, Inc. (CARL)

at www.tipranks.com (Thu, 6-Aug 7:11 AM)

BioAge Labs, Inc. (BIOA) Gets a Buy from Citi

at www.tipranks.com (Thu, 6-Aug 7:10 AM)

Andy Hsieh Reiterates Hold on BioAge as Strong Cash Runway Offsets Execution and Clinical Surrogate Uncertainties

at www.tipranks.com (Wed, 5-Aug 9:45 PM)

BioAge Labs GAAP EPS of -$0.58 beats by $0.03, revenue of $2.45M beats by $0.95M

at seekingalpha.com (Wed, 5-Aug 6:02 PM)

BioAge Labs, Inc. (BIOA) Gets a Buy from Piper Sandler

at www.tipranks.com (Wed, 5-Aug 3:05 AM)

Analysts Offer Insights on NA Companies: Central Bancompany (CBC) and BioAge Labs, Inc. (BIOA)

at www.tipranks.com (Mon, 3-Aug 9:20 AM)

Shrader Reiterates Buy on BioAge, Citing Differentiated NLRP3 Strategy and Attractive Valuation with Unchanged $40 Price Target

at www.tipranks.com (Mon, 3-Aug 7:35 AM)